International Journal of Cancer Management

Published by: Kowsar

Halting Schistosoma haematobium - Associated Bladder Cancer

Monica C. Botelho 1 , 2 , * , Helena Alves 2 and Joachim Richter 3
Authors Information
1 INSA, National Institute of Health Dr. Ricardo Jorge, Porto, Portugal
2 I3S, Instituto de Investigacao e Inovacao da Universidade do Porto, Portugal
3 Institute of Tropical Medicine and International Health, Charite – Universitatsmedizin Berlin, Germany
Article information
  • International Journal of Cancer Management: September 2017, 10 (9); e9430
  • Published Online: September 30, 2017
  • Article Type: Review Article
  • Received: October 21, 2016
  • Revised: December 7, 2016
  • Accepted: September 16, 2017
  • DOI: 10.5812/ijcm.9430

To Cite: Botelho M C, Alves H, Richter J. Halting Schistosoma haematobium - Associated Bladder Cancer, Int J Cancer Manag. 2017 ; 10(9):e9430. doi: 10.5812/ijcm.9430.

Copyright © 2017, Cancer Research Center (CRC), Shahid Beheshti University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Evidence Acquisition
3. Results
4. Conclusions
  • 1. Adamson PB. Schistosomiasis in antiquity. Med Hist. 1976; 20(2): 176-88[PubMed]
  • 2. Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J. Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis. 2006; 6(7): 411-25[DOI][PubMed]
  • 3. Botelho MC, Machado JC, Brindley PJ, Correia da Costa JM. Targeting molecular signaling pathways of Schistosoma haemotobium infection in bladder cancer. Virulence. 2011; 2(4): 267-79[PubMed]
  • 4. Mone H, Holtfreter MC, Allienne JF, Mintsa-Nguema R, Ibikounle M, Boissier J, et al. Introgressive hybridizations of Schistosoma haematobium by Schistosoma bovis at the origin of the first case report of schistosomiasis in Corsica (France, Europe). Parasitol Res. 2015; 114(11): 4127-33[DOI][PubMed]
  • 5. Mott KE. Contrasts in the control of schistosomiasis. Mem Inst Oswaldo Cruz. 1989; 84 Suppl 1: 3-19[PubMed]
  • 6. World Health Organization . Weekly epidemiological record, 90th year; 30 January 2015. 2015; 90
  • 7. WHO . Schistosomiasis: progress Report 2001-2011, strategic plan 2012–2020. . 2013;
  • 8. Holtfreter MC, Moné H, Müller-Stöver I, Mouahid G, Richter J. Schistosoma haematobium infections acquired in Corsica, France, August 2013. Euro Surveill. 2014; 19(22): 20821
  • 9. Mostafa MH, Sheweita SA, O'Connor PJ. Relationship between schistosomiasis and bladder cancer. Clin Microbiol Rev. 1999; 12(1): 97-111[PubMed]
  • 10. Zhong X, Isharwal S, Naples JM, Shiff C, Veltri RW, Shao C, et al. Hypermethylation of genes detected in urine from Ghanaian adults with bladder pathology associated with Schistosoma haematobium infection. PLoS One. 2013; 8(3)[DOI][PubMed]
  • 11. Shiff C, Veltri R, Naples J, Quartey J, Otchere J, Anyan W, et al. Ultrasound verification of bladder damage is associated with known biomarkers of bladder cancer in adults chronically infected with Schistosoma haematobium in Ghana. Trans R Soc Trop Med Hyg. 2006; 100(9): 847-54[DOI][PubMed]
  • 12. IARC Biological agents, A review of human carcinogens. IARC monographs on the evaluation of carcinogenic risks to humans/WHO. IARC. 2012; 100: 1–441
  • 13. Botelho MC, Alves H, Barros A, Rinaldi G, Brindley PJ, Sousa M. The role of estrogens and estrogen receptor signaling pathways in cancer and infertility: the case of schistosomes. Trend Parasitol. 2015; 31(6): 246-50[DOI]
  • 14. Botelho MC, Vale N, Gouveia MJ, Rinaldi G, Santos J, Santos LL, et al. Tumour-like phenotypes in urothelial cells after exposure to antigens from eggs of Schistosoma haematobium: an oestrogen-DNA adducts mediated pathway? Int J Parasitol. 2013; 43(1): 17-26[DOI][PubMed]
  • 15. Botelho MC, Soares R, Vale N, Ribeiro R, Camilo V, Almeida R, et al. Schistosoma haematobium: identification of new estrogenic molecules with estradiol antagonistic activity and ability to inactivate estrogen receptor in mammalian cells. Exp Parasitol. 2010; 126(4): 526-35[DOI][PubMed]
  • 16. Yabroff KR, Davis WW, Lamont EB, Fahey A, Topor M, Brown ML, et al. Patient time costs associated with cancer care. J Natl Cancer Inst. 2007; 99(1): 14-23[DOI][PubMed]
  • 17. Noyes K, Singer EA, Messing EM. Healthcare economics of bladder cancer: cost-enhancing and cost-reducing factors. Curr Opin Urol. 2008; 18(5): 533-9[DOI][PubMed]
  • 18. Kulkarni GS, Alibhai SM, Finelli A, Fleshner NE, Jewett MA, Lopushinsky SR, et al. Cost-effectiveness analysis of immediate radical cystectomy versus intravesical Bacillus Calmette-Guerin therapy for high-risk, high-grade (T1G3) bladder cancer. Cancer. 2009; 115(23): 5450-9[DOI][PubMed]
  • 19. Cooksley CD, Avritscher EB, Grossman HB, Sabichi AL, Dinney CP, Pettaway C, et al. Clinical model of cost of bladder cancer in the elderly. Urology. 2008; 71(3): 519-25[DOI][PubMed]
  • 20. Konety BR, Allareddy V. Influence of post-cystectomy complications on cost and subsequent outcome. J Urol. 2007; 177(1): 280-7[DOI][PubMed]
  • 21. Doehring E, Ehrich JH. [Effectiveness of praziquantel as an antihelmintic agent in the treatment of bilharziasis]. Monatsschr Kinderheilkd. 1986; 134(5): 282-4[PubMed]
  • 22. Doehring E, Ehrich JH, Bremer HJ. Reversibility of urinary tract abnormalities due to Schistosoma haematobium infection. Kidney Int. 1986; 30(4): 582-5[PubMed]
  • 23. Richter J. Evolution of schistosomiasis-induced pathology after therapy and interruption of exposure to schistosomes: a review of ultrasonographic studies. Acta Trop. 2000; 77(1): 111-31[PubMed]
  • 24. Richter J. The impact of chemotherapy on morbidity due to schistosomiasis. Acta Trop. 2003; 86(2-3): 161-83[PubMed]
  • 25. Homeida MA, el Tom I, Nash T, Bennett JL. Association of the therapeutic activity of praziquantel with the reversal of Symmers' fibrosis induced by Schistosoma mansoni. Am J Trop Med Hyg. 1991; 45(3): 360-5[PubMed]
  • 26. Nagi MA. Evaluation of a programme for control of schistosoma haematobium infection in Yemen. East Mediterr Health J. 2005; 11(5-6): 977-87[PubMed]
  • 27. Zhang Y, Koukounari A, Kabatereine N, Fleming F, Kazibwe F, Tukahebwa E, et al. Parasitological impact of 2-year preventive chemotherapy on schistosomiasis and soil-transmitted helminthiasis in Uganda. BMC Med. 2007; 5: 27[DOI][PubMed]
  • 28. Ndeffo Mbah ML, Gilbert JA, Galvani AP. Evaluating the potential impact of mass praziquantel administration for HIV prevention in Schistosoma haematobium high-risk communities. Epidemics. 2014; 7: 22-7[DOI][PubMed]
  • 29. Ouedraogo H, Drabo F, Zongo D, Bagayan M, Bamba I, Pima T, et al. Schistosomiasis in school-age children in Burkina Faso after a decade of preventive chemotherapy. Bull World Health Organ. 2016; 94(1): 37-45[DOI][PubMed]
  • 30. van der Werf MJ, de Vlas SJ, Brooker S, Looman CW, Nagelkerke NJ, Habbema JD, et al. Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop. 2003; 86(2-3): 125-39[PubMed]
  • 31. Hotez PJ, Fenwick A, Kjetland EF. Africa's 32 cents solution for HIV/AIDS. PLoS Negl Trop Dis. 2009; 3(5)[DOI][PubMed]
  • 32. King CH. Parasites and poverty: the case of schistosomiasis. Acta Trop. 2010; 113(2): 95-104[DOI][PubMed]
  • 33. Gabrielli AF, Toure S, Sellin B, Sellin E, Ky C, Ouedraogo H, et al. A combined school- and community-based campaign targeting all school-age children of Burkina Faso against schistosomiasis and soil-transmitted helminthiasis: performance, financial costs and implications for sustainability. Acta Trop. 2006; 99(2-3): 234-42[DOI][PubMed]
  • 34. Fenwick A. Waterborne infectious diseases--could they be consigned to history? Science. 2006; 313(5790): 1077-81[DOI][PubMed]
  • 35. Poggensee G, Kiwelu I, Saria M, Richter J, Krantz I, Feldmeier H. Schistosomiasis of the lower reproductive tract without egg excretion in urine. Am J Trop Med Hyg. 1998; 59(5): 782-3[PubMed]
  • 36. Richter J, Bode JG, Blondin D, Kircheis G, Kubitz R, Holtfreter MC, et al. Severe liver fibrosis caused by Schistosoma mansoni: management and treatment with a transjugular intrahepatic portosystemic shunt. Lancet Infect Dis. 2015; 15(6): 731-7[DOI][PubMed]
  • 37. Koukounari A, Donnelly CA, Sacko M, Keita AD, Landoure A, Dembele R, et al. The impact of single versus mixed schistosome species infections on liver, spleen and bladder morbidity within Malian children pre- and post-praziquantel treatment. BMC Infect Dis. 2010; 10: 227[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments